Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990-1992): Structure and results of a population-based registry

Journal of Clinical Epidemiology

Volumn 49, Issue 7, 1996, Pages 769-773

  Rzany, Berthold ^a,c   Mockenhaupt, Maja ^a   Baur, Susan ^a   Schröder, Werner ^a   Stocker, Ulrich ^a   Mueller, Judit ^a   Holländer, Norbert ^a   Bruppacher, Rudolf ^b   Schöpf, Erwin ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF BASEL   (Switzerland)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Defined daily doses; Erythema exsudativum multiforme majus; Registry; Serious cutaneous adverse reactions; Stevens Johnson syndrome; Toxic epidermal necrolysis

Indexed keywords

ARTICLE; ERYTHEMA MULTIFORME; GERMANY; HUMAN; INTENSIVE CARE; POPULATION RESEARCH; PRIORITY JOURNAL; REGISTER; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS;

EID: 0030198337     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/0895-4356(96)00035-2     Document Type: Article

References (19)

1. 1. Roujeau JC, Chosidow O, Saiag P, Guillaume JC. Toxic epidermal necrolysis (Lyell's syndrome). Am Acad Dermatol 1990; 23: 1039-1058.
2. 2. Lyell A. Requiem for toxic epidermal necrolysis. Br J Dermatol 1990; 122: 837-846.
3. 3. Kaupinnen K. Cutaneous reactions to drugs. Acta Dermato-venerologica 1972; 52(Suppl. 68).
4. 4. Naldi L, Locati F, Marchesi L, Cainelli T. Incidence of toxic epidermal necrolysis in Italy. Arch Dermatol 1990; 126: 1103-1104.
5. 5. Roujeau JC, Guillaume JC, Fabre JP, Penso D, Fléchet ML, Girre JP. Toxic epidermal necrolysis (Lyell's syndrome): Incidence and drug etiology in France, 1981-1985. Arch Dermatol 1990; 126: 37-42.
6. 6. Schöpf E, Stühmer A, Rzany B, Victor N, Zentgraf R, Kapp JF. Toxic epidermal necrolysis and Stevens-Johnson syndrome. An epidemiologic study from West-Germany. Arch Dermatol 1991; 127: 839-842.
7. 7. Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Roujeau JC. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 1993; 129: 92-96.
8. 8. Keisu M, Ekman E, Wiholm B-E. Comparing risk estimates of sulfa induced agranulocytosis from the Swedish Drug Monitoring System and a case control study. Eur J Clin Pharmacol 1992; 43: 211-214.
9. 9. Schwabe U, Paffrath D. Arzneiverordnungsreport 1991, 1992, 1993. Gustav Fischer Verlag 1991; 7: 279-290; 1992; 8: 275-286; 1993; 9: 267-277.
10. 9. Schwabe U, Paffrath D. Arzneiverordnungsreport 1991, 1992, 1993. Gustav Fischer Verlag 1991; 7: 279-290; 1992; 8: 275-286; 1993; 9: 267-277.
11. 9. Schwabe U, Paffrath D. Arzneiverordnungsreport 1991, 1992, 1993. Gustav Fischer Verlag 1991; 7: 279-290; 1992; 8: 275-286; 1993; 9: 267-277.
12. 10. Guillaume JC, Roujeau JC, Revuz J, Penso D, Touraine R. The culprit drugs in 87 cases of toxic epidermal necrolysis (Lyell's syndrome). Arch Dermatol 1987; 123: 1166-1170.
13. 11. Rogers AS. Adverse drug events: Identification and attribution. Drug Intell Clin Pharmacol 1987; 21: 915-920.
14. 12. Chan HL, Stern R, Arndt KA, Langlois J, Jick S, Jick H, Walker AW. The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. Arch Dermatol 1990; 126: 43-47.
15. 13. Strom BL, Carson JL, Halpern AC, Schinnar R, Snyder ES, Stolley PD. Using a claims database to investigate drug-induced Stevens-Johnson syndrome. Stat Med 1991; 10: 565-576.
16. 14. Stern RS, Chan HL, Usefulness of case report literature in determining drugs responsible for toxic epidermal necrolysis. J Am Acad Dermatol 1989; 21: 317-322.
17. 15. Correia O, Chosidow O, Saiag Ph, Bastuji-Garin S, Revuz J, Roujeau JC. Evolving pattern of drug-induced toxic epidermal necrolysis. Dermatology 1993; 186: 32-37.
18. 16. Ruiz-Maldonado R. Acute disseminated epidermal necrosis types 1, 2 and 3: Study of sixty cases. J Am Acad Dermatol 1985; 13: 623-635.
19. 17. Feely J, Moriarty S, O'Connor P. Stimulating reporting of adverse reactions by using a fee. Br Med J 1990; 300: 22-23.